The Right to Try and Access Experimental Therapies for COVID-19 Patients
As the race to find drugs and medicines to cure and prevent COVID-19 reaches the crescendo, many countries including Kenya are now participating in various human clinical trials for among other experimental drugs Remdesivir, chloroquine or hydroxychloroquine, lopinavir + ritonavir, or with Interferonbeta. These drugs have not been approved for public use and can only be used in the context of the clinical trials in many countries. In this context, the role of drug regulation is going to be extremely important especially at the national level.